News & Analysis on Clinical Trial Services & Contract Research And Development
Newly-approved pearlescent pigments that can produce sparkly metallic, satiny and shimmery finishes on drug coatings could be used as one additional step in the fight against counterfeiting, say its developers, EMD Chemicals - part of part of German...
Researchers believe they have discovered how the HIV virus avoids the human body's natural defences paving the way for a HIV-specific cell drug treatment that vastly improves on the drugs that are currently available.
Argos Therapeutics has announced that dosing has been initiated in a Phase I/II clinical trial to test the activity and safety of AGS-003, a personalised immunotherapy for advanced kidney cancer (metastatic renal cell carcinoma).
Alantos Pharmaceuticals has initiated a Phase I trial for its lead compound for diabetes, a disease that commands a global market estimated at $11bn (€8.6bn) and is expected to grow by more than 50 per cent by the end of the decade.
Bionas has launched a product for in vitro profiling the metabolic activity of cells to understand cellular function that could prove highly useful in drug discovery and development.
Patients suffering from Alzheimer's disease are one step closer to receiving Novartis's Exelon as a transdermal patch instead of a capsule following an international clinical study which showed that the new delivery method reduces side effects without...
A cartridge shortage that forced Amylin and Eli Lilly to ask 40,000 physicians in the US to stop prescribing their injectable diabetes drug Byetta to new patients has come to an end thanks to a boost in production by contract manufacturer Baxter.